Subscribe
Share
Share
Embed
Covering FTA Negotiations, WHO South-East Asia, Emergency Use Authorization, Tuberculosis, Malaysia. Explore major regulatory updates including WHO South-East Asia’s health priorities, Malaysia’s new Cross-Border Insolvency Act, Emergency Use Authorization advances, and tuberculosis elimination efforts within ASEAN.
Regulatory news, updates, and insights for countries in the ASEAN region presented by the Carver Agents team
Welcome to Carver's ASEAN Regulatory Updates for September 05, 2026.
The Indonesian Deposit Insurance Corporation, known as LPS, has announced an increase in the deposit insurance interest rate for Rupiah deposits. Effective July 1, 2026, the rate for Bank Umum is set at 3.75 percent, while for Bank Perkreditan Rakyat, or BPR, it is 6.25 percent. The foreign currency deposit insurance rate remains unchanged at 2.00 percent. LPS is also advancing preparations for the Program Penjaminan Polis, targeting implementation by January 2028, which will extend deposit insurance protections to the insurance sector. Additionally, readiness for the Program Restrukturisasi Perbankan continues, supported by new government regulations. Banks and BPRs are required to comply with updated premium payments and interest rate guarantees as part of these measures.
In related Indonesian regulatory news, the Financial Services Authority of Indonesia, or OJK, has imposed 1,277 sanctions on market participants up to August 31, 2026. These sanctions include administrative fines, prohibitions, and written orders for violations of capital market regulations and reporting compliance. OJK emphasizes the importance of strict adherence to capital market rules, including proper fund flow from public offerings, accurate financial reporting, and governance obligations. Market participants must ensure timely submission of periodic, incidental, governance-related, and supporting profession reports to avoid administrative sanctions and maintain transparency.
The Indonesian Food and Drug Authority, BPOM, is preparing to support innovation in health technology by strengthening regulatory frameworks for precision medicine and cell therapy. Based on BPOM Regulation No. 8 of 2025 and No. 24 of 2025, these frameworks aim to accelerate innovation while ensuring safety, efficacy, and quality. Special regulatory pathways will be implemented for each stage of product development. Collaboration among government, industry, academia, and healthcare providers is encouraged to advance these medical technologies.
Indonesia also conducted a two-day tabletop exercise simulating a pandemic scenario to test vaccine development and approval processes. This exercise involved government agencies, industry players, and research institutions, focusing on rapid vaccine development, production, and regulatory approval within a 100-day target. Key requirements include integrating early detection systems such as portable rapid test devices and genomic sequencing, ensuring readiness of national vaccine manufacturers for mass production, and refining regulatory pathways to balance speed with safety.
Turning to Singapore, the Health Sciences Authority, or HSA, has charged five men for alleged trafficking of etomidate vaporiser pods. Enforcement operations involved collaboration with the Singapore Police Force, Central Narcotics Bureau, and Immigration and Checkpoints Authority. The charges highlight the strict enforcement of the Tobacco and Vaporisers Control Act 1993, which regulates etomidate and its analogues. Compliance with laws prohibiting trafficking, importing, manufacturing, or supplying illegal health products, including unregistered cough syrup, is mandatory. Cooperation with enforcement agencies during investigations is also required.
In Malaysia, the Cross-Border Insolvency Act 2026, known as Act 877, came into force on August 28, 2026. This legislation adapts the UNCITRAL Model Law to improve cross-border insolvency proceedings. It establishes mechanisms to enhance legal certainty, facilitate cooperation between courts and authorities, and protect creditor interests. Entities involved in cross-border insolvency cases must adhere to the procedures under Act 877, collaborate with courts and relevant authorities, and work to maximize debtor asset value while supporting business rescue efforts.
Thailand has revised its visa-free stay policy, reducing the duration from 60 days to 30 days for eligible passport holders from 60 countries, including Malaysia. This change took effect on September 1, 2026. Additionally, land-border visa-exempt entries are now limited to twice per calendar year for most countries, with certain exceptions. These new rules impact cross-border travel and tourism, requiring travelers and businesses to adjust to the updated entry restrictions.
Finally, the World Health Organization's Seventy-ninth Session of the Regional Committee for South-East Asia will convene next week. Health ministers from ASEAN countries and Timor-Leste will discuss strategic priorities such as improving access to specialized care for aging populations, accelerating tuberculosis elimination, leveraging digital health and artificial intelligence, and strengthening health system resilience.
That wraps up today's regulatory updates. Visit carveragents.ai for more information.